Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 9909082
[patent_doc_number] => 20150064283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 14/535439
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5366
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14535439
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/535439 | PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION | Nov 6, 2014 | Abandoned |
Array
(
[id] => 10760561
[patent_doc_number] => 20160106715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'METHODS TO INHIBIT INFECTION DURING WOUND HEALING WITH TOPICAL COMPOSITIONS INCLUDING AMINO ACIDS'
[patent_app_type] => utility
[patent_app_number] => 14/518449
[patent_app_country] => US
[patent_app_date] => 2014-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13887
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14518449
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/518449 | Methods to inhibit infection during wound healing with topical compositions including amino acids | Oct 19, 2014 | Issued |
14/121769 | Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women | Oct 15, 2014 | Abandoned |
Array
(
[id] => 11913918
[patent_doc_number] => 09782090
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-10-10
[patent_title] => 'Method and system enabling photoplethysmograph measurement of volume status'
[patent_app_type] => utility
[patent_app_number] => 14/511306
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15573
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511306
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511306 | Method and system enabling photoplethysmograph measurement of volume status | Oct 9, 2014 | Issued |
Array
(
[id] => 11046077
[patent_doc_number] => 20160243034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE AND CYCLOPHOSPHAMIDE'
[patent_app_type] => utility
[patent_app_number] => 15/025819
[patent_app_country] => US
[patent_app_date] => 2014-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3595
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025819
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/025819 | PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE AND CYCLOPHOSPHAMIDE | Sep 28, 2014 | Abandoned |
14/460082 | METHOD AND SYSTEM ENABLING PHOTOPLETHYSMOGRAPH MEASUREMENT OF VOLUME STATUS | Aug 13, 2014 | Abandoned |
Array
(
[id] => 10996439
[patent_doc_number] => 20160193385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'MESOSTRUCTURED POLYMER MEMBRANES AND OTHER ARTICLES'
[patent_app_type] => utility
[patent_app_number] => 14/911792
[patent_app_country] => US
[patent_app_date] => 2014-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15223
[patent_no_of_claims] => 167
[patent_no_of_ind_claims] => 118
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911792 | MESOSTRUCTURED POLYMER MEMBRANES AND OTHER ARTICLES | Aug 13, 2014 | Abandoned |
Array
(
[id] => 9793429
[patent_doc_number] => 20150005373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'Method of Treating Acne'
[patent_app_type] => utility
[patent_app_number] => 14/447434
[patent_app_country] => US
[patent_app_date] => 2014-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 6795
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14447434
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/447434 | Method of treating acne | Jul 29, 2014 | Issued |
Array
(
[id] => 9838596
[patent_doc_number] => 20150030676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'STABLIZED MODIFIED RELEASE FOLIC ACID DERIVATIVE COMPOSITION, ITS THERAPEUTIC USE AND METHODS OF MANUFACTURE'
[patent_app_type] => utility
[patent_app_number] => 14/445949
[patent_app_country] => US
[patent_app_date] => 2014-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17404
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14445949
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/445949 | STABLIZED MODIFIED RELEASE FOLIC ACID DERIVATIVE COMPOSITION, ITS THERAPEUTIC USE AND METHODS OF MANUFACTURE | Jul 28, 2014 | Abandoned |
Array
(
[id] => 11023552
[patent_doc_number] => 20160220507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'KIT FOR SUSTAINED TRANSDERMAL DRUG DELIVERY USING LIQUID OR SEMISOLID FORMULATIONS AND METHOD OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/903979
[patent_app_country] => US
[patent_app_date] => 2014-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8410
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903979
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/903979 | KIT FOR SUSTAINED TRANSDERMAL DRUG DELIVERY USING LIQUID OR SEMISOLID FORMULATIONS AND METHOD OF USING THE SAME | Jul 9, 2014 | Abandoned |
Array
(
[id] => 9798689
[patent_doc_number] => 20150010633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/323115
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10399
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323115 | NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF | Jul 2, 2014 | Abandoned |
Array
(
[id] => 9798687
[patent_doc_number] => 20150010632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/323089
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11341
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323089
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323089 | NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF | Jul 2, 2014 | Abandoned |
Array
(
[id] => 10805254
[patent_doc_number] => 20160151412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'COMBINATION OF XENON WITH AN NMDA RECEPTOR ANTAGONIST FOR FIGHTING A NEURODEGENERATIVE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/903809
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3294
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903809
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/903809 | COMBINATION OF XENON WITH AN NMDA RECEPTOR ANTAGONIST FOR FIGHTING A NEURODEGENERATIVE DISEASE | Jul 2, 2014 | Abandoned |
Array
(
[id] => 10435719
[patent_doc_number] => 20150320731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'TABLETED COMPOSITIONS CONTAINING ATAZANAVIR'
[patent_app_type] => utility
[patent_app_number] => 14/322478
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10911
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14322478
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/322478 | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR | Jul 1, 2014 | Abandoned |
Array
(
[id] => 9792335
[patent_doc_number] => 20150004279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING EXERCISE PERFORMANCE'
[patent_app_type] => utility
[patent_app_number] => 14/310359
[patent_app_country] => US
[patent_app_date] => 2014-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11923
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14310359
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/310359 | Compositions and methods for enhancing exercise performance | Jun 19, 2014 | Issued |
Array
(
[id] => 9805274
[patent_doc_number] => 20150017219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'SOLVENT METHODS FOR PREPARING CRYSTALLINE MACROLIDE PARTICULATES, COMPOSITIONS, AND ARTICLES CONTAINING PARTICULATES'
[patent_app_type] => utility
[patent_app_number] => 14/303309
[patent_app_country] => US
[patent_app_date] => 2014-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12378
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14303309
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/303309 | Solvent methods for preparing crystalline macrolide particulates, compositions, and articles containing particulates | Jun 11, 2014 | Issued |
Array
(
[id] => 11928589
[patent_doc_number] => 09795567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Immediate release formulations and dosage forms of gamma-hydroxybutyrate'
[patent_app_type] => utility
[patent_app_number] => 14/295098
[patent_app_country] => US
[patent_app_date] => 2014-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10130
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295098
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/295098 | Immediate release formulations and dosage forms of gamma-hydroxybutyrate | Jun 2, 2014 | Issued |
Array
(
[id] => 10767924
[patent_doc_number] => 20160114081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR BLOOD VESSEL TISSUE REPAIR AND ENGINEERING'
[patent_app_type] => utility
[patent_app_number] => 14/894962
[patent_app_country] => US
[patent_app_date] => 2014-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11019
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894962
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894962 | METHODS AND COMPOSITIONS FOR BLOOD VESSEL TISSUE REPAIR AND ENGINEERING | Jun 1, 2014 | Abandoned |
Array
(
[id] => 10749807
[patent_doc_number] => 20160095958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'BONE REGENERATION USING STROMAL VASCULAR FRACTION, PLATELET-DERIVED GROWTH FACTOR-RICH HYDROGEL, THREE-DIMENSIONAL PRINTED POLY-EPSILON-CAPROLACTONE SCAFFOLDS'
[patent_app_type] => utility
[patent_app_number] => 14/893286
[patent_app_country] => US
[patent_app_date] => 2014-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18938
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893286
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893286 | BONE REGENERATION USING STROMAL VASCULAR FRACTION, PLATELET-DERIVED GROWTH FACTOR-RICH HYDROGEL, THREE-DIMENSIONAL PRINTED POLY-EPSILON-CAPROLACTONE SCAFFOLDS | May 27, 2014 | Abandoned |
Array
(
[id] => 10737372
[patent_doc_number] => 20160083522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'Arginine-Grafted Bioreducible Polymer Systems and Use in Treatment of Cardiac Conditions'
[patent_app_type] => utility
[patent_app_number] => 14/891289
[patent_app_country] => US
[patent_app_date] => 2014-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11567
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891289
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/891289 | Arginine-Grafted Bioreducible Polymer Systems and Use in Treatment of Cardiac Conditions | May 13, 2014 | Abandoned |